Rates and risk factors for recurrence of retinopathy of prematurity after laser or intravitreal anti–vascular endothelial growth factor monotherapy

Conclusion: Laser, IVR, and IVB are effective for Type 1 ROP. Retinopathy of prematurity recurrence requiring re-treatment was encountered as late as 50 weeks of postmenstrual age after IVB or IVR but earlier after laser. Longer follow-up for infants treated with anti–vascular endothelial growth factor is needed, especially in patients with significant risk factors such as an early postmenstrual age at initial treatment, Zone I ROP, low Apgar score, and multiple births.
Source: RETINA - Category: Opthalmology Tags: Original Study Source Type: research